Get the latest delivered to your inbox
Privacy Policy

Now Reading

Novo Nordisk #15 on Top Green Companies in the World

Novo Nordisk #15 on Top Green Companies in the World

Published 06-09-15

Submitted by Novo Nordisk

In one of the foremost assessments of corporate environmental performance, Novo Nordisk moved up 12 places to rank #15 on the 2015 Newsweek Green Rankings. Newsweek Green Rankings rate the world’s largest companies on corporate sustainability and environmental impact.

Novo Nordisk has previously been recognised for its strong and consistent sustainability performance by the Corporate Knights Global 100 Most Sustainable Companies index and was also the first pharmaceutical company in the world to publish an Environmental Profit and Loss (E P&L) account. An E P&L is a way to place a monetary value on the environmental impacts of an organisation and its supply chain and goes beyond what is accounted for in existing financial disclosures.

Newsweek Green Rankings are done in partnership with Corporate Knights CapitalHIP (Human Impact + Profit) Investor Inc., and leading sustainability minds from nongovernmental organizations and the academic and accounting communities.

The full 2015 results can be found online at: http://www.newsweek.com/green-2015.

Newsweek Green Rankings Methodology
The U.S. 500 consists of the 500 largest publicly-traded companies headquartered in the U.S. by market capitalization as at 31 December 2014. The Global 500 consists of the 500 largest publicly-traded companies in the world by market capitalization as at 31 December 2014.

Data is obtained from primary sources including annual reports, audited financial statements, proxy statements and sustainability reports. Secondary data is obtained from HIP Investor, Bloomberg and the CDP. All companies are contacted for data verification once all available items of data have been obtained.

For more information about the methodology, please see: http://s.newsweek.com/sites/www.newsweek.com/files/newsweek-green-rankings-final-methodology_2015.pdf

Novo Nordisk logo

Novo Nordisk

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.

More from Novo Nordisk

Join today and get the latest delivered to your inbox